| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.22e-09 | 25 | 100 | 6 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.68e-09 | 27 | 100 | 6 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 2.03e-07 | 51 | 100 | 6 | GO:0005048 | |
| GeneOntologyMolecularFunction | structural molecule activity | NUP98 LAMA3 FLG2 POM121C ECM1 ENAM EFEMP1 POM121 LMNA MUC17 NPAP1 MMRN2 POM121B MUC4 NUP153 | 3.60e-05 | 891 | 100 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA6 DLG5 NUP98 SPAG9 WNK1 TRRAP DDB1 LPIN1 PARP10 NCOR1 ARID1B ANAPC1 TNRC6A AKAP13 MUC1 CDH1 TRIM37 NUP153 RBFOX2 | 3.78e-05 | 1356 | 100 | 19 | GO:0060090 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.49e-05 | 188 | 100 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA6 DLG5 NUP98 SPAG9 WNK1 TRRAP DDB1 LPIN1 PARP10 NCOR1 ARID1B TNRC6A AKAP13 MUC1 TRIM37 NUP153 RBFOX2 | 5.93e-05 | 1160 | 100 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.48e-04 | 4 | 100 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.52e-04 | 21 | 100 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | histone H2A ubiquitin ligase activity | 3.68e-04 | 6 | 100 | 2 | GO:0141053 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA6 NUP98 TRRAP LPIN1 PARP10 NCOR1 ARID1B MUC1 TRIM37 RBFOX2 | 5.15e-04 | 562 | 100 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.09e-03 | 10 | 100 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | cobalamin binding | 1.09e-03 | 10 | 100 | 2 | GO:0031419 | |
| GeneOntologyMolecularFunction | peptide binding | 1.10e-03 | 318 | 100 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.21e-03 | 42 | 100 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 1.59e-03 | 12 | 100 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 1.87e-03 | 13 | 100 | 2 | GO:0005078 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 2.52e-08 | 18 | 105 | 5 | GO:0006999 | |
| GeneOntologyBiologicalProcess | import into nucleus | NUP98 POM121C CDAN1 POM121 LMNA NFATC3 NPAP1 POM121B CDH1 NUP153 | 7.97e-08 | 201 | 105 | 10 | GO:0051170 |
| GeneOntologyBiologicalProcess | nuclear transport | NUP98 POM121C WNK1 CDAN1 POM121 LMNA NFATC3 NPAP1 AKAP13 POM121B CDH1 NUP153 | 5.09e-07 | 378 | 105 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | NUP98 POM121C WNK1 CDAN1 POM121 LMNA NFATC3 NPAP1 AKAP13 POM121B CDH1 NUP153 | 5.09e-07 | 378 | 105 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 5.95e-07 | 96 | 105 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 6.90e-07 | 195 | 105 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | nucleus organization | 2.55e-06 | 170 | 105 | 8 | GO:0006997 | |
| GeneOntologyBiologicalProcess | nuclear export | 4.78e-06 | 185 | 105 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | NUP98 NBEA STIL CUBN POM121C WNK1 AP3M1 MICALL1 POM121 LMNA DCP1B NFATC3 NPAP1 FAM83D POM121B CDH1 TRIM37 NUP153 | 9.25e-06 | 1091 | 105 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | NUP98 CUBN POM121C AP3M1 POM121 LMNA NFATC3 NPAP1 POM121B CDH1 TRIM37 NUP153 | 1.23e-05 | 515 | 105 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | NUP98 POM121C POM121 LMNA DCP1B NFATC3 NPAP1 POM121B CDH1 NUP153 | 1.61e-05 | 362 | 105 | 10 | GO:0034504 |
| GeneOntologyBiologicalProcess | RNA transport | 3.18e-05 | 175 | 105 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 3.18e-05 | 175 | 105 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 3.54e-05 | 178 | 105 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | mRNA transport | 9.89e-05 | 145 | 105 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.23e-04 | 217 | 105 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | chromatin organization | RNF168 UBN2 TRRAP DDB1 TASOR2 EZHIP CDAN1 BPTF PARP10 NCOR1 ARID1B LMNA BICRAL TRIM37 | 1.79e-04 | 896 | 105 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | intracellular transport | NUP98 SPAG9 CD320 POM121C WNK1 AP3M1 MADD MICALL1 CDAN1 POM121 ZFYVE9 LMNA NFATC3 NPAP1 AKAP13 POM121B CDH1 TRIM37 NUP153 | 1.80e-04 | 1496 | 105 | 19 | GO:0046907 |
| GeneOntologyBiologicalProcess | immunoglobulin production | 2.35e-04 | 241 | 105 | 7 | GO:0002377 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.86e-04 | 249 | 105 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | adaptive immune response | RC3H2 RNF168 IGLV2-33 IGLV2-23 ORAI1 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 C4A C4B DUSP10 MUC4 | 3.31e-04 | 838 | 105 | 13 | GO:0002250 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.38e-04 | 65 | 105 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 3.43e-04 | 27 | 105 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | DACH1 CDK11A STIL WNK1 TRRAP DDB1 ARID1B ANAPC1 CRNN ANKRD17 FAM83D MUC1 TRIM37 | 3.59e-04 | 845 | 105 | 13 | GO:0010564 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RNF168 UBN2 TRRAP DDB1 TASOR2 EZHIP CDAN1 BPTF PARP10 NCOR1 ARID1B LMNA BICRAL TRIM37 | 5.38e-04 | 999 | 105 | 14 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear pore | 1.20e-05 | 101 | 105 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.85e-05 | 109 | 105 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | nuclear membrane | NUP98 POM121C LPIN1 POM121 LMNA NPAP1 ANKRD17 POM121B NUP153 | 6.69e-05 | 349 | 105 | 9 | GO:0031965 |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.93e-04 | 166 | 105 | 6 | GO:0019814 | |
| GeneOntologyCellularComponent | symbiont cell surface | 6.86e-04 | 8 | 105 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 8.79e-04 | 9 | 105 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | inclusion body | 1.10e-03 | 90 | 105 | 4 | GO:0016234 | |
| MousePheno | thin myocardium | 1.35e-05 | 85 | 86 | 6 | MP:0002652 | |
| Domain | SEA | 6.76e-08 | 22 | 93 | 5 | PF01390 | |
| Domain | SEA | 8.61e-08 | 23 | 93 | 5 | PS50024 | |
| Domain | SEA_dom | 8.61e-08 | 23 | 93 | 5 | IPR000082 | |
| Domain | SEA | 5.55e-07 | 14 | 93 | 4 | SM00200 | |
| Domain | - | 7.54e-07 | 15 | 93 | 4 | 3.30.70.960 | |
| Domain | Ago_hook | 7.33e-05 | 3 | 93 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 7.33e-05 | 3 | 93 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 7.33e-05 | 3 | 93 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 7.33e-05 | 3 | 93 | 2 | PF16608 | |
| Domain | Anaphylatoxin_comp_syst | 2.43e-04 | 5 | 93 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.43e-04 | 5 | 93 | 2 | IPR001840 | |
| Domain | ANATO | 5.07e-04 | 7 | 93 | 2 | SM00104 | |
| Domain | ANATO | 5.07e-04 | 7 | 93 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 5.07e-04 | 7 | 93 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.07e-04 | 7 | 93 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 5.07e-04 | 7 | 93 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 6.74e-04 | 8 | 93 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 6.74e-04 | 8 | 93 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 6.74e-04 | 8 | 93 | 2 | IPR019742 | |
| Domain | A2M_N | 1.08e-03 | 10 | 93 | 2 | PF01835 | |
| Domain | A2M_N | 1.08e-03 | 10 | 93 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.08e-03 | 10 | 93 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.08e-03 | 10 | 93 | 2 | PS00477 | |
| Domain | A2M | 1.08e-03 | 10 | 93 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.08e-03 | 10 | 93 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.08e-03 | 10 | 93 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.08e-03 | 10 | 93 | 2 | PF07703 | |
| Domain | A2M_recep | 1.08e-03 | 10 | 93 | 2 | PF07677 | |
| Domain | A2M_comp | 1.08e-03 | 10 | 93 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.08e-03 | 10 | 93 | 2 | IPR001599 | |
| Domain | EGF_1 | 1.73e-03 | 255 | 93 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.94e-03 | 261 | 93 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.10e-03 | 265 | 93 | 6 | PS01186 | |
| Domain | VWD | 2.81e-03 | 16 | 93 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.81e-03 | 16 | 93 | 2 | IPR001846 | |
| Domain | VWFD | 2.81e-03 | 16 | 93 | 2 | PS51233 | |
| Domain | VWD | 2.81e-03 | 16 | 93 | 2 | PF00094 | |
| Domain | C345C | 3.18e-03 | 17 | 93 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.56e-03 | 18 | 93 | 2 | IPR008930 | |
| Domain | NTR | 3.97e-03 | 19 | 93 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 3.97e-03 | 19 | 93 | 2 | IPR018933 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.33e-08 | 49 | 83 | 7 | MM14837 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.60e-08 | 16 | 83 | 5 | M27410 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.06e-08 | 55 | 83 | 7 | MM14917 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.67e-08 | 17 | 83 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.18e-07 | 21 | 83 | 5 | MM15706 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.32e-07 | 41 | 83 | 6 | MM15200 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.94e-07 | 23 | 83 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.74e-07 | 26 | 83 | 5 | M27483 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.38e-07 | 53 | 83 | 6 | M27212 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.51e-06 | 40 | 83 | 5 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.49e-06 | 42 | 83 | 5 | MM15039 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.70e-06 | 114 | 83 | 7 | MM15361 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.06e-06 | 43 | 83 | 5 | MM14609 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 7.36e-06 | 80 | 83 | 6 | M6121 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 7.91e-06 | 47 | 83 | 5 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 9.78e-06 | 84 | 83 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.08e-05 | 50 | 83 | 5 | MM14610 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.09e-05 | 24 | 83 | 4 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.19e-05 | 51 | 83 | 5 | MM15151 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.25e-05 | 58 | 83 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.25e-05 | 58 | 83 | 5 | MM14736 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.65e-05 | 60 | 83 | 5 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.12e-05 | 62 | 83 | 5 | M546 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 3.54e-05 | 32 | 83 | 4 | M29579 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | COG2 SP3 CD52 RNF168 NUP98 MUC19 MUC16 POM121C TRRAP DDB1 ENAM MGAT5 POM121 MUC17 WDR20 C4A C4B MUC1 POM121B MUC4 NUP153 | 3.89e-05 | 1389 | 83 | 21 | MM15307 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.92e-05 | 65 | 83 | 5 | MM15147 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 4.01e-05 | 33 | 83 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 4.53e-05 | 34 | 83 | 4 | M27041 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.88e-05 | 68 | 83 | 5 | M27303 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.88e-05 | 68 | 83 | 5 | MM14921 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.09e-05 | 35 | 83 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.70e-05 | 36 | 83 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 5.70e-05 | 36 | 83 | 4 | M27245 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.85e-05 | 115 | 83 | 6 | M19752 | |
| Pathway | REACTOME_SUMOYLATION | 6.07e-05 | 169 | 83 | 7 | MM14919 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 6.36e-05 | 37 | 83 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 6.36e-05 | 37 | 83 | 4 | M27038 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.87e-05 | 73 | 83 | 5 | MM14948 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 7.85e-05 | 39 | 83 | 4 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.88e-05 | 77 | 83 | 5 | M27226 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 9.58e-05 | 41 | 83 | 4 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.16e-04 | 43 | 83 | 4 | M26975 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.20e-04 | 82 | 83 | 5 | MM15394 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.27e-04 | 44 | 83 | 4 | M109 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.50e-04 | 86 | 83 | 5 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.50e-04 | 86 | 83 | 5 | M27206 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.50e-04 | 86 | 83 | 5 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.51e-04 | 46 | 83 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.64e-04 | 47 | 83 | 4 | M27395 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.67e-04 | 139 | 83 | 6 | M715 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.74e-04 | 140 | 83 | 6 | M27484 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.88e-04 | 142 | 83 | 6 | M27660 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.06e-04 | 92 | 83 | 5 | MM14951 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | CNTN4 COG2 SP3 CD52 RNF168 NUP98 MUC16 MUC12 POM121C TRRAP DDB1 ENAM MGAT5 POM121 MUC17 WDR20 C4A MUC1 MUC4 NUP153 | 2.77e-04 | 1475 | 83 | 20 | M19806 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.82e-04 | 54 | 83 | 4 | M29594 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.97e-04 | 59 | 83 | 4 | M27606 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.99e-04 | 106 | 83 | 5 | M27458 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | NUP98 POM121C PARP10 IGLV2-23 IGLV2-14 IGLV2-11 IGLV2-8 MGAT5 POM121 NUP153 | 4.31e-04 | 471 | 83 | 10 | M39009 |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 4.35e-04 | 166 | 83 | 6 | M608 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 4.52e-04 | 61 | 83 | 4 | M27581 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.53e-04 | 109 | 83 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.93e-04 | 111 | 83 | 5 | M27416 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 5.06e-04 | 6 | 83 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 5.06e-04 | 6 | 83 | 2 | M22047 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 5.06e-04 | 6 | 83 | 2 | MM15083 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 6.27e-04 | 117 | 83 | 5 | M19248 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.69e-04 | 250 | 83 | 7 | M27554 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 7.06e-04 | 7 | 83 | 2 | MM14685 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.06e-04 | 7 | 83 | 2 | M46421 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 7.22e-04 | 69 | 83 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 7.22e-04 | 69 | 83 | 4 | M27150 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.04e-04 | 71 | 83 | 4 | M27394 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 8.04e-04 | 71 | 83 | 4 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 8.04e-04 | 71 | 83 | 4 | M27203 | |
| Pathway | REACTOME_SUMOYLATION | 8.61e-04 | 189 | 83 | 6 | M27214 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 8.63e-04 | 32 | 83 | 3 | M27900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.37e-04 | 8 | 83 | 2 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 9.37e-04 | 8 | 83 | 2 | M27031 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 9.40e-04 | 74 | 83 | 4 | M48006 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.20e-03 | 9 | 83 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.20e-03 | 9 | 83 | 2 | M46436 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.32e-03 | 138 | 83 | 5 | M29805 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.32e-03 | 37 | 83 | 3 | M29790 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.38e-03 | 82 | 83 | 4 | M27110 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.38e-03 | 82 | 83 | 4 | M27250 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.49e-03 | 10 | 83 | 2 | M48013 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.51e-03 | 84 | 83 | 4 | M725 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.54e-03 | 143 | 83 | 5 | M27275 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.57e-03 | 85 | 83 | 4 | M1870 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.72e-03 | 87 | 83 | 4 | M27205 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 1.79e-03 | 41 | 83 | 3 | M29748 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.82e-03 | 11 | 83 | 2 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.82e-03 | 11 | 83 | 2 | MM1430 | |
| Pathway | REACTOME_M_PHASE | 1.97e-03 | 387 | 83 | 8 | MM15364 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 2.18e-03 | 12 | 83 | 2 | MM15105 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.18e-03 | 12 | 83 | 2 | MM1368 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 2.20e-03 | 155 | 83 | 5 | M522 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 2.37e-03 | 95 | 83 | 4 | M29842 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.55e-03 | 234 | 83 | 6 | MM14898 | |
| Pathway | WP_VITAMIN_B12_DISORDERS | 2.56e-03 | 13 | 83 | 2 | M39778 | |
| Pubmed | NUP98 LAMA3 MUC12 POM121C WNK1 MADD POM121 TNRC6A NFYA ANKRD17 AKAP13 C4A BICRAL DUSP10 NOSTRIN MUC1 NUP153 RBFOX2 | 9.41e-15 | 486 | 106 | 18 | 20936779 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | NCOA6 NUP98 MUC19 TNRC6B POM121C NCOR1 ARID1B SALL2 NUP153 PDZD2 | 5.05e-12 | 123 | 106 | 10 | 26912792 |
| Pubmed | NCOA6 KLF8 NUP98 DACH1 TNRC6B CDK11A SPAG9 FLG2 UBN2 POM121C RFX1 TRRAP DDB1 BPTF NCOR1 ARID1B SALL2 DCP1B NFATC3 WDR20 ZBTB21 TNRC6A NFYA ANKRD17 | 6.77e-12 | 1429 | 106 | 24 | 35140242 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.25e-11 | 18 | 106 | 6 | 18834073 | |
| Pubmed | 2.72e-10 | 87 | 106 | 8 | 12465718 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 SP3 NUP98 POM121C WNK1 TASOR2 NCOR1 POM121 LMNA AKAP13 CLINT1 NEURL4 NUP153 | 7.40e-10 | 430 | 106 | 13 | 35044719 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 NUP98 TNRC6B POM121C AP3M1 NCOR1 ARID1B POM121 LMNA DCP1B TNRC6A ANKRD17 NUP153 | 1.54e-09 | 457 | 106 | 13 | 32344865 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 NUP98 CDK11A SPAG9 RFX1 TRRAP MICALL1 BPTF NCOR1 LMNA ANAPC1 EIF4B ZBTB21 ANKRD17 ARHGEF6 NUP153 | 1.78e-09 | 774 | 106 | 16 | 15302935 |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 23053434 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 2.75e-08 | 3 | 106 | 3 | 30802453 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 35507432 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 27483328 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 24939955 | ||
| Pubmed | Expression of mucin (MUC) genes in mucoepidermoid carcinoma. | 2.75e-08 | 3 | 106 | 3 | 21072847 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 2.75e-08 | 3 | 106 | 3 | 17592322 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 35879412 | ||
| Pubmed | CNTN4 SPAG9 UBN2 POM121C WNK1 CASZ1 POM121 PER3 DIP2C ADGRF5 POM121B NEURL4 | 3.80e-08 | 493 | 106 | 12 | 15368895 | |
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 14697343 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.10e-07 | 4 | 106 | 3 | 17900573 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 1.10e-07 | 4 | 106 | 3 | 39024979 | |
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 1.10e-07 | 4 | 106 | 3 | 18198997 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.11e-07 | 38 | 106 | 5 | 12791264 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CDSN DACH1 TNRC6B SPAG9 UBN2 NCOR1 SALL2 LMNA EIF4B ZBTB21 CLINT1 | 1.22e-07 | 444 | 106 | 11 | 34795231 |
| Pubmed | NCOA6 DACH1 TNRC6B SPAG9 UBN2 RFX1 TRRAP BPTF NCOR1 ARID1B ANAPC1 CLINT1 | 1.22e-07 | 549 | 106 | 12 | 38280479 | |
| Pubmed | 2.10e-07 | 43 | 106 | 5 | 1249422 | ||
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 18035521 | ||
| Pubmed | 3.31e-07 | 47 | 106 | 5 | 814163 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NUP98 DACH1 CDK11A SPAG9 RFX1 TRRAP CASZ1 BPTF NCOR1 SALL2 ANAPC1 ZBTB21 NFYA ANKRD17 | 3.56e-07 | 857 | 106 | 14 | 25609649 |
| Pubmed | 3.69e-07 | 48 | 106 | 5 | 11955599 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 4.10e-07 | 49 | 106 | 5 | 8951372 | |
| Pubmed | E-cadherin is required for intestinal morphogenesis in the mouse. | 8.26e-07 | 24 | 106 | 4 | 22766025 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | NUP98 POM121C TRRAP ARID1B POM121 LMNA ANAPC1 ANKRD17 CDH1 NUP153 | 1.02e-06 | 440 | 106 | 10 | 34244565 |
| Pubmed | CUBN UBN2 WNK1 AP3M1 MADD EZHIP ORAI1 ARID1B EIF4B ANKRD17 CDH1 ULK2 TRIM37 ARHGEF6 NUP153 | 1.06e-06 | 1084 | 106 | 15 | 11544199 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.07e-06 | 341 | 106 | 9 | 32971831 | |
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 1.09e-06 | 109 | 106 | 6 | 9074928 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 NUP98 DACH1 CDK11A UBN2 RFX1 TASOR2 BPTF NCOR1 ARID1B LMNA EIF4B CLINT1 NUP153 | 1.27e-06 | 954 | 106 | 14 | 36373674 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.36e-06 | 351 | 106 | 9 | 38297188 | |
| Pubmed | TNRC6B POM121C TRRAP DDB1 BPTF ARID1B SALL2 ANAPC1 WDR20 RTL9 ZBTB21 TNRC6A CRNN ANKRD17 BICRAL | 1.52e-06 | 1116 | 106 | 15 | 31753913 | |
| Pubmed | Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. | 1.52e-06 | 8 | 106 | 3 | 26510501 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DLG5 CDK11A UBN2 WNK1 NCOR1 SALL2 NFATC3 ANAPC1 TNRC6A TRIM37 ZMYM6 | 1.92e-06 | 588 | 106 | 11 | 38580884 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 TNRC6B STIL DDB1 MICALL1 NCOR1 NFATC3 EIF4B TNRC6A CLINT1 NEURL4 TRIM37 RBFOX2 | 2.07e-06 | 853 | 106 | 13 | 28718761 |
| Pubmed | Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis. | 2.28e-06 | 9 | 106 | 3 | 19251658 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 DLG5 STIL WNK1 MADD MICALL1 DCP1B NFATC3 EIF4B ZBTB21 ANKRD17 AKAP13 CLINT1 | 2.29e-06 | 861 | 106 | 13 | 36931259 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK11A SPAG9 POM121C WNK1 RFX1 MICALL1 POM121 DCP1B WDR20 RTL9 ZBTB21 CRNN SDF2L1 CLINT1 NEURL4 ARHGEF6 | 2.53e-06 | 1321 | 106 | 16 | 27173435 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.04e-06 | 497 | 106 | 10 | 36774506 | |
| Pubmed | Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. | 3.12e-06 | 33 | 106 | 4 | 16618389 | |
| Pubmed | NUP98 NBEA SPAG9 MADD NCOR1 ARID1B PTPRB ZFYVE9 WDR20 TNRC6A DUSP10 CLINT1 NEURL4 NUP153 | 3.80e-06 | 1049 | 106 | 14 | 27880917 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 3.97e-06 | 77 | 106 | 5 | 24927568 | |
| Pubmed | NCOA6 MUC16 NBEA POM121C RFX1 AP3M1 CASZ1 NCOR1 ARID1B ANKRD17 SDF2L1 | 4.18e-06 | 638 | 106 | 11 | 31182584 | |
| Pubmed | NUP98 MUC16 TNRC6B NBEA SPAG9 FLG2 BTBD3 TASOR2 NCOR1 WDR20 TNRC6A CLINT1 | 4.59e-06 | 777 | 106 | 12 | 35844135 | |
| Pubmed | 5.75e-06 | 83 | 106 | 5 | 28794006 | ||
| Pubmed | 6.12e-06 | 225 | 106 | 7 | 12168954 | ||
| Pubmed | CNTN4 TNRC6B NBEA UBN2 DDB1 NCOR1 NFATC3 ANAPC1 ZBTB21 ANKRD17 NEURL4 NUP153 SH3BP5 | 7.68e-06 | 963 | 106 | 13 | 28671696 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ONECUT2 NCOA6 RNF168 NUP98 UBN2 POM121C TRRAP DDB1 CASZ1 BPTF NCOR1 LMNA ANAPC1 NUP153 RBFOX2 | 9.08e-06 | 1294 | 106 | 15 | 30804502 |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 9.20e-06 | 2 | 106 | 2 | 16565498 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15998580 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 9.20e-06 | 2 | 106 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 9.20e-06 | 2 | 106 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 9.20e-06 | 2 | 106 | 2 | 17645767 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29067356 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29791863 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12207352 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16194893 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 9.20e-06 | 2 | 106 | 2 | 27758680 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22387014 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28885228 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 9.20e-06 | 2 | 106 | 2 | 23749435 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 9.20e-06 | 2 | 106 | 2 | 3037333 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11726230 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 9.20e-06 | 2 | 106 | 2 | 6950384 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 9.20e-06 | 2 | 106 | 2 | 8428773 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29223400 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30011875 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 9.20e-06 | 2 | 106 | 2 | 21345967 | |
| Pubmed | Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer. | 9.20e-06 | 2 | 106 | 2 | 27974701 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2572548 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2302180 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25531720 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 9.20e-06 | 2 | 106 | 2 | 18091514 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29080553 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6589636 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20598042 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 9.20e-06 | 2 | 106 | 2 | 25339671 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17728371 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27003157 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6149580 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6149581 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12115608 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 3542363 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24039759 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2387317 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27283771 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16908004 | ||
| Interaction | TNRC6A interactions | NCOA6 RC3H2 DLG5 TNRC6B STIL WNK1 DCP1B ANAPC1 TNRC6A ANKRD17 TRIM37 RBFOX2 | 1.82e-08 | 280 | 102 | 12 | int:TNRC6A |
| Interaction | SMG7 interactions | NCOA6 RC3H2 DACH1 TNRC6B CDK11A STIL NCOR1 ARID1B SALL2 TNRC6A ANKRD17 TRIM37 | 7.62e-08 | 319 | 102 | 12 | int:SMG7 |
| Interaction | NUP43 interactions | NCOA6 NUP98 MUC19 TNRC6B UBN2 POM121C DDB1 TASOR2 BPTF NCOR1 ARID1B SALL2 POM121 LMNA NUP153 PDZD2 | 9.67e-08 | 625 | 102 | 16 | int:NUP43 |
| Interaction | NUP35 interactions | NCOA6 NUP98 TNRC6B POM121C NCOR1 ARID1B POM121 LMNA DCP1B TNRC6A ANKRD17 NUP153 PDZD2 | 2.26e-07 | 424 | 102 | 13 | int:NUP35 |
| Interaction | APC interactions | NUP98 LAMA3 STIL POM121C POM121 ANKRD17 AKAP13 C4A NOSTRIN MUC1 NUP153 RBFOX2 | 6.39e-07 | 389 | 102 | 12 | int:APC |
| Interaction | FAM193A interactions | 1.59e-06 | 71 | 102 | 6 | int:FAM193A | |
| Interaction | SEC16A interactions | RC3H2 KLF8 TNRC6B STIL BTBD3 LMNA DCP1B TNRC6A FAM83D CLINT1 ULK2 TRIM37 | 1.66e-06 | 426 | 102 | 12 | int:SEC16A |
| Interaction | MARF1 interactions | 3.96e-06 | 128 | 102 | 7 | int:MARF1 | |
| Interaction | YTHDF3 interactions | 4.44e-06 | 246 | 102 | 9 | int:YTHDF3 | |
| Interaction | ASF1A interactions | 4.90e-06 | 249 | 102 | 9 | int:ASF1A | |
| Interaction | STIL interactions | 5.54e-06 | 190 | 102 | 8 | int:STIL | |
| Interaction | HNF4A interactions | 1.09e-05 | 275 | 102 | 9 | int:HNF4A | |
| Interaction | ADGRF5 interactions | 1.47e-05 | 10 | 102 | 3 | int:ADGRF5 | |
| Interaction | SMAD3 interactions | NCOA6 DACH1 CDK11A BPTF ARID1B ZFYVE9 LMNA EIF4B CDH1 ARHGEF6 NUP153 | 1.64e-05 | 447 | 102 | 11 | int:SMAD3 |
| Interaction | CNOT4 interactions | 1.95e-05 | 65 | 102 | 5 | int:CNOT4 | |
| Interaction | SOX2 interactions | NCOA6 DLG5 NUP98 DACH1 LAMA3 CDK11A UBN2 ECM1 RFX1 DDB1 BPTF NCOR1 ARID1B SALL2 ANAPC1 TNRC6A ANKRD17 C4A CLINT1 RBFOX2 | 2.56e-05 | 1422 | 102 | 20 | int:SOX2 |
| Interaction | YAP1 interactions | NCOA6 DACH1 TNRC6B SPAG9 FLG2 UBN2 RFX1 TRRAP BPTF NCOR1 ARID1B LMNA ANAPC1 EIF4B CLINT1 CDH1 TRIM37 | 3.34e-05 | 1095 | 102 | 17 | int:YAP1 |
| Interaction | CEP152 interactions | 3.52e-05 | 179 | 102 | 7 | int:CEP152 | |
| Interaction | DTX2 interactions | 4.57e-05 | 330 | 102 | 9 | int:DTX2 | |
| Interaction | HELZ interactions | 4.90e-05 | 257 | 102 | 8 | int:HELZ | |
| Interaction | HNF1B interactions | 5.14e-05 | 190 | 102 | 7 | int:HNF1B | |
| Interaction | RNF43 interactions | DLG5 ROR1 NUP98 TNRC6B POM121C POM121 TNRC6A CLINT1 CDH1 NUP153 | 6.16e-05 | 427 | 102 | 10 | int:RNF43 |
| Interaction | QPRT interactions | 6.77e-05 | 84 | 102 | 5 | int:QPRT | |
| Interaction | SIRT6 interactions | NUP98 POM121C TRRAP DDB1 TASOR2 ARID1B POM121 LMNA ANAPC1 ANKRD17 CDH1 NUP153 | 7.90e-05 | 628 | 102 | 12 | int:SIRT6 |
| Interaction | CNOT10 interactions | 8.18e-05 | 141 | 102 | 6 | int:CNOT10 | |
| Interaction | SYNE3 interactions | DLG5 NUP98 TNRC6B STIL POM121C NCOR1 DCP1B ANAPC1 TNRC6A TRIM37 | 8.51e-05 | 444 | 102 | 10 | int:SYNE3 |
| Interaction | NASP interactions | 8.82e-05 | 207 | 102 | 7 | int:NASP | |
| Interaction | CNOT3 interactions | 8.82e-05 | 207 | 102 | 7 | int:CNOT3 | |
| Interaction | FBXO22 interactions | 9.11e-05 | 540 | 102 | 11 | int:FBXO22 | |
| Interaction | NR1I2 interactions | 1.01e-04 | 48 | 102 | 4 | int:NR1I2 | |
| Interaction | NINL interactions | DLG5 TNRC6B STIL DDB1 NCOR1 IGLV2-14 LMNA DCP1B TNRC6A TRIM37 | 1.10e-04 | 458 | 102 | 10 | int:NINL |
| Interaction | PTPRB interactions | 1.29e-04 | 51 | 102 | 4 | int:PTPRB | |
| Interaction | EIF4ENIF1 interactions | 1.43e-04 | 300 | 102 | 8 | int:EIF4ENIF1 | |
| Interaction | SLX4 interactions | CDSN CDK11A UBN2 AP3M1 DDB1 NCOR1 SALL2 LMNA ZBTB21 CLINT1 NUP153 | 1.51e-04 | 572 | 102 | 11 | int:SLX4 |
| Interaction | NUP155 interactions | ROR1 NUP98 TNRC6B POM121C AP3M1 POM121 ZFYVE9 LMNA TNRC6A NUP153 | 1.53e-04 | 477 | 102 | 10 | int:NUP155 |
| Interaction | YWHAG interactions | NCOA6 RC3H2 DLG5 WNK1 TRRAP MICALL1 LPIN1 LMNA DCP1B NFATC3 EIF4B WDR20 ZBTB21 ANKRD17 AKAP13 CLINT1 ARHGEF6 | 1.66e-04 | 1248 | 102 | 17 | int:YWHAG |
| Interaction | CLEC4A interactions | 1.78e-04 | 103 | 102 | 5 | int:CLEC4A | |
| Interaction | POU5F1 interactions | MUC16 CUBN UBN2 TRRAP DDB1 CDAN1 BPTF ARID1B SALL2 ANKRD17 CDH1 | 1.81e-04 | 584 | 102 | 11 | int:POU5F1 |
| Interaction | DCP1A interactions | 2.00e-04 | 166 | 102 | 6 | int:DCP1A | |
| Interaction | CEP85 interactions | 2.20e-04 | 169 | 102 | 6 | int:CEP85 | |
| Interaction | NCAPH2 interactions | 2.20e-04 | 169 | 102 | 6 | int:NCAPH2 | |
| Interaction | CREBBP interactions | NCOA6 SP3 KLF8 NUP98 DACH1 TRRAP DDB1 NCOR1 ARID1B NFYA CDH1 | 2.25e-04 | 599 | 102 | 11 | int:CREBBP |
| Interaction | EGR2 interactions | 2.35e-04 | 171 | 102 | 6 | int:EGR2 | |
| Interaction | CDC16 interactions | 2.56e-04 | 246 | 102 | 7 | int:CDC16 | |
| Interaction | TEAD1 interactions | 2.74e-04 | 176 | 102 | 6 | int:TEAD1 | |
| Interaction | CNOT2 interactions | 2.91e-04 | 178 | 102 | 6 | int:CNOT2 | |
| Interaction | WWTR1 interactions | 2.92e-04 | 422 | 102 | 9 | int:WWTR1 | |
| Interaction | DEAF1 interactions | 3.11e-04 | 64 | 102 | 4 | int:DEAF1 | |
| Interaction | ZFP36 interactions | 3.19e-04 | 181 | 102 | 6 | int:ZFP36 | |
| Interaction | YWHAZ interactions | DLG5 CDSN WNK1 MADD MICALL1 NCOR1 LMNA DCP1B NFATC3 EIF4B WDR20 ZBTB21 ANKRD17 AKAP13 CDH1 TRIM37 ARHGEF6 | 3.19e-04 | 1319 | 102 | 17 | int:YWHAZ |
| Interaction | NUP37 interactions | 3.30e-04 | 65 | 102 | 4 | int:NUP37 | |
| Interaction | ALG13 interactions | 3.38e-04 | 183 | 102 | 6 | int:ALG13 | |
| Interaction | SNRNP40 interactions | RC3H2 UBN2 POM121C DDB1 TASOR2 NCOR1 ARID1B POM121 LMNA ZBTB21 RBFOX2 | 3.80e-04 | 637 | 102 | 11 | int:SNRNP40 |
| Interaction | GIGYF2 interactions | 3.83e-04 | 263 | 102 | 7 | int:GIGYF2 | |
| Interaction | NR3C1 interactions | NCOA6 NUP98 MUC16 NBEA POM121C RFX1 AP3M1 CASZ1 NCOR1 ARID1B ANKRD17 SDF2L1 NUP153 RBFOX2 | 3.89e-04 | 974 | 102 | 14 | int:NR3C1 |
| Interaction | SUZ12 interactions | RC3H2 TRRAP DDB1 TASOR2 EZHIP BPTF RTL9 TNRC6A SDF2L1 MUC4 TRIM37 | 4.16e-04 | 644 | 102 | 11 | int:SUZ12 |
| Interaction | YWHAH interactions | NCOA6 DLG5 STIL WNK1 MADD MICALL1 DCP1B NFATC3 EIF4B WDR20 ZBTB21 ANKRD17 AKAP13 CLINT1 ARHGEF6 | 4.23e-04 | 1102 | 102 | 15 | int:YWHAH |
| Cytoband | 22q11.2 | 3.87e-07 | 120 | 106 | 6 | 22q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 5.63e-05 | 419 | 106 | 7 | chr22q11 | |
| Cytoband | 22q13.1 | 1.03e-03 | 85 | 106 | 3 | 22q13.1 | |
| Cytoband | 1q21 | 1.25e-03 | 91 | 106 | 3 | 1q21 | |
| Cytoband | 7q11.23 | 1.51e-03 | 97 | 106 | 3 | 7q11.23 | |
| GeneFamily | CD molecules|Mucins | 2.52e-10 | 21 | 77 | 6 | 648 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 2.15e-06 | 89 | 77 | 6 | 353 | |
| GeneFamily | Nucleoporins | 3.37e-04 | 32 | 77 | 3 | 1051 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 3.71e-04 | 7 | 77 | 2 | 1350 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.32e-04 | 9 | 77 | 2 | 1234 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.95e-03 | 161 | 77 | 4 | 593 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.04e-03 | 25 | 77 | 2 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 ROR1 NUP98 SPAG9 STIL TRRAP BPTF MGAT5 ZFYVE9 NFATC3 ANKRD17 AKAP13 BICRAL CLINT1 SLC23A2 TRIM37 NUP153 RBFOX2 | 6.06e-09 | 856 | 103 | 18 | M4500 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NCOA6 RC3H2 TNRC6B WNK1 NCOR1 EIF4B TNRC6A NFYA SDF2L1 RBFOX2 PDZD2 | 2.34e-06 | 467 | 103 | 11 | M1347 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.69e-06 | 221 | 103 | 8 | M39222 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NCOA6 RC3H2 TNRC6B WNK1 NCOR1 EIF4B TNRC6A NFYA SDF2L1 RBFOX2 PDZD2 | 3.29e-06 | 484 | 103 | 11 | MM999 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NUP98 STIL TRRAP BPTF MGAT5 ZFYVE9 ANKRD17 TRIM37 NUP153 RBFOX2 | 1.55e-05 | 466 | 103 | 10 | M13522 |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP | 5.42e-05 | 168 | 103 | 6 | M6704 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.79e-05 | 170 | 103 | 6 | M5880 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.94e-10 | 192 | 106 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-07 | 175 | 106 | 7 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-07 | 175 | 106 | 7 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.45e-07 | 179 | 106 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-07 | 180 | 106 | 7 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-07 | 184 | 106 | 7 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-07 | 184 | 106 | 7 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.42e-07 | 188 | 106 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.80e-07 | 191 | 106 | 7 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.80e-07 | 191 | 106 | 7 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.94e-07 | 192 | 106 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 192 | 106 | 7 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-07 | 195 | 106 | 7 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.19e-07 | 200 | 106 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.95e-06 | 155 | 106 | 6 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-06 | 162 | 106 | 6 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-06 | 163 | 106 | 6 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.10e-06 | 168 | 106 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 3.10e-06 | 168 | 106 | 6 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | 3.21e-06 | 169 | 106 | 6 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-06 | 170 | 106 | 6 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-06 | 170 | 106 | 6 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-06 | 176 | 106 | 6 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-06 | 176 | 106 | 6 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 4.06e-06 | 176 | 106 | 6 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 4.06e-06 | 176 | 106 | 6 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.19e-06 | 177 | 106 | 6 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.19e-06 | 177 | 106 | 6 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.19e-06 | 177 | 106 | 6 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.47e-06 | 179 | 106 | 6 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.47e-06 | 179 | 106 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.47e-06 | 179 | 106 | 6 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.62e-06 | 180 | 106 | 6 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.92e-06 | 182 | 106 | 6 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.92e-06 | 182 | 106 | 6 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.08e-06 | 183 | 106 | 6 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 183 | 106 | 6 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 5.08e-06 | 183 | 106 | 6 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-06 | 184 | 106 | 6 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.24e-06 | 184 | 106 | 6 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.41e-06 | 185 | 106 | 6 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.41e-06 | 185 | 106 | 6 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.41e-06 | 185 | 106 | 6 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-06 | 185 | 106 | 6 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-06 | 185 | 106 | 6 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.57e-06 | 186 | 106 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | 3827fa80e558b642f3e0036f5ee1a8b69f437e30 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | 1bf696eb03422ea507d3efe58dda1d442a65225d | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | ebe4d1216cc0d4c079b413d5a5460cfd3a4af922 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.75e-06 | 187 | 106 | 6 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.75e-06 | 187 | 106 | 6 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 5.75e-06 | 187 | 106 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.93e-06 | 188 | 106 | 6 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 5.93e-06 | 188 | 106 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.11e-06 | 189 | 106 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 6.11e-06 | 189 | 106 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | facs-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-06 | 190 | 106 | 6 | d55b3ad4d1ec172b042bc08127506c354f87f69d | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.30e-06 | 190 | 106 | 6 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 190 | 106 | 6 | 2803eb02209591a63fe13e834e4e0f8014e1aa34 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.30e-06 | 190 | 106 | 6 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-06 | 190 | 106 | 6 | d4aefae2d3164db6a9e953c54af0151501e9d1da | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-06 | 190 | 106 | 6 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-06 | 190 | 106 | 6 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | PND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 191 | 106 | 6 | 96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 6.49e-06 | 191 | 106 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.49e-06 | 191 | 106 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 192 | 106 | 6 | e4dd24aefdf13cd4206714f02fde2288f3173ffc | |
| ToppCell | droplet-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 42e4dafbe3e8b4a3c25d594f06b95430a1dd8b28 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 192 | 106 | 6 | dfa6adc776621f4b51d731b796c0421855b2297c | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 192 | 106 | 6 | 6b69bb8fab9b470850eba1a070a500435ec233cd | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 192 | 106 | 6 | 517bc24b9ad5e2b5a3609ca55d7327c4700db9db | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.89e-06 | 193 | 106 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 193 | 106 | 6 | ce5c3ab79900aa6f394c894267340167009c6149 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-06 | 193 | 106 | 6 | 1b6317b740cad2439f08b9e9895426d861e7a161 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 193 | 106 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | facs-Lung-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-06 | 193 | 106 | 6 | e10ef60a82f182680955a775adc6659325e92310 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | 4893b922e129711d5886bd4f3ee106e9e7065971 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 193 | 106 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-06 | 193 | 106 | 6 | f5861cfa4401b476229a7c61cd64abad79a4bbfc | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 193 | 106 | 6 | 634fdd157cd1efeebf6ecc810bc45e138331451a | |
| ToppCell | droplet-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-06 | 193 | 106 | 6 | 95c9c63bddfed1a84393ccd3578cfe65bc0c1c05 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | 9235849c7ef3236454eced413acff6274e991a0e | |
| ToppCell | E16.5-Endothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | c048b7e08a08bb645a28c5b904bd87304d7a4f55 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | 7062b152367987aba12a2f6f653b647c74b4e160 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.09e-06 | 194 | 106 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | 855ddaf1ec91e6fe1f1617900216a5742e96dda2 | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-06 | 194 | 106 | 6 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-06 | 194 | 106 | 6 | 23f2a627226aaed468c55adc42ab22e051dfe7fe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-06 | 195 | 106 | 6 | 27d1f228103ff5d8941aa8a8d15726cd09298a30 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 195 | 106 | 6 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.30e-06 | 195 | 106 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 195 | 106 | 6 | dfc5da514fb34a2c318a5c4c61f44049fa43960e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.52e-06 | 196 | 106 | 6 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-06 | 196 | 106 | 6 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.52e-06 | 196 | 106 | 6 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; MCF7; HT_HG-U133A | 2.57e-06 | 195 | 101 | 8 | 6234_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.77e-06 | 197 | 101 | 8 | 7230_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.82e-05 | 184 | 101 | 7 | 2946_UP | |
| Drug | Contact Lens Solutions | 1.95e-05 | 2 | 101 | 2 | ctd:D018639 | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 2.48e-05 | 193 | 101 | 7 | 7097_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 2.56e-05 | 194 | 101 | 7 | 1856_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 5697_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 7238_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 6271_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 2362_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 6241_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 2369_UP | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 4579_DN | |
| Disease | peeling skin syndrome (is_implicated_in) | 1.66e-04 | 6 | 99 | 2 | DOID:0060283 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 2.31e-04 | 7 | 99 | 2 | C0399367 | |
| Disease | Malignant neoplasm of breast | NCOA6 ROR1 NUP98 CUBN WNK1 MICALL1 NCOR1 ARID1B EFEMP1 PER3 DIP2C CDH1 | 2.55e-04 | 1074 | 99 | 12 | C0006142 |
| Disease | beta-defensin 119 measurement | 3.08e-04 | 8 | 99 | 2 | EFO_0801419 | |
| Disease | common bile duct neoplasm (is_marker_for) | 3.08e-04 | 8 | 99 | 2 | DOID:4608 (is_marker_for) | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 4.10e-04 | 43 | 99 | 3 | EFO_0004735, GO_0031427 | |
| Disease | dry eye syndrome (is_marker_for) | 4.93e-04 | 10 | 99 | 2 | DOID:10140 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 4.93e-04 | 10 | 99 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Colorectal Carcinoma | 5.98e-04 | 702 | 99 | 9 | C0009402 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 8.48e-04 | 13 | 99 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | ONECUT2 DLG5 MUC19 CUBN POM121C MADD LPIN1 MGAT5 AKAP13 NOSTRIN | 9.23e-04 | 904 | 99 | 10 | EFO_0004736 |
| Disease | cholangiocarcinoma (is_marker_for) | 1.32e-03 | 64 | 99 | 3 | DOID:4947 (is_marker_for) | |
| Disease | triacylglycerol 48:1 measurement | 1.47e-03 | 17 | 99 | 2 | EFO_0010404 | |
| Disease | otitis media (biomarker_via_orthology) | 1.47e-03 | 17 | 99 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.63e-03 | 69 | 99 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Congenital Fiber Type Disproportion | 1.65e-03 | 18 | 99 | 2 | C0546264 | |
| Disease | Antihypertensive use measurement | 2.03e-03 | 265 | 99 | 5 | EFO_0009927 | |
| Disease | asparaginase hypersensitivity | 2.24e-03 | 77 | 99 | 3 | EFO_0004881 | |
| Disease | quinolinic acid measurement | 2.24e-03 | 21 | 99 | 2 | EFO_0010528 | |
| Disease | Moderate albuminuria | 2.50e-03 | 80 | 99 | 3 | HP_0012594 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.93e-03 | 24 | 99 | 2 | DOID:12894 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.96e-03 | 85 | 99 | 3 | DOID:3910 (is_marker_for) | |
| Disease | urate measurement | 3.17e-03 | 895 | 99 | 9 | EFO_0004531 | |
| Disease | response to gemcitabine | 3.18e-03 | 25 | 99 | 2 | GO_0036272 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NVVSGGGSFSSSQPI | 91 | Q8NAP1 | |
| SQTNPQGAVSSTVSG | 131 | Q15052 | |
| GSVTGSQSNAVSPTP | 1231 | P0C0L5 | |
| GGSSKSQSSTSPEGQ | 411 | O60239 | |
| SSTPVGNESTAAGNT | 1376 | Q86V15 | |
| GGISTTNVSTPDTAG | 466 | Q12802 | |
| NSAGTGPSSATVNVT | 881 | Q8IWV2 | |
| SSDSTNGTGVQGGQI | 501 | Q9Y2F9 | |
| SGSLQGPQTPQSTGS | 1256 | Q8NFD5 | |
| SITGSSNVGDTLPTG | 146 | Q9Y2T2 | |
| GSQVNSAGSLTSSPT | 1956 | O75179 | |
| QPGQSSSSSQTSGVS | 191 | Q15517 | |
| SGSGGTTSNSQVITG | 2166 | Q12830 | |
| GGVASSTPINASTGS | 126 | Q9UI36 | |
| GSVNGSPLLSTSGAS | 2166 | Q00975 | |
| TTTSLGAQPSQTSQG | 831 | Q8IWY9 | |
| GEQASGAPISSTSTG | 171 | P26436 | |
| SNVAATSAGPSNVGT | 556 | Q9HBD1 | |
| PSTQNGSLTTEGGAQ | 86 | O43251 | |
| GVTGAATSPSTNGAS | 851 | O60271 | |
| SEQGGTPQNVATSSS | 286 | Q9H1A4 | |
| TITTQTGPTGAATQG | 4386 | Q8WXI7 | |
| ASGQTQTSEPASSGS | 781 | Q99102 | |
| QSGQGQSTQTGSRVT | 1251 | Q5D862 | |
| TVPSSVSGVTVNNSG | 641 | P23467 | |
| GTTNTTSNPFGSTSG | 131 | P52948 | |
| QVGGPISSGSSASSV | 606 | P02545 | |
| PNSTVSNTSTEGFGG | 831 | Q8WXG6 | |
| SGSFPSQVTATSGNG | 356 | Q14677 | |
| SGAGGTSTSVTPKQS | 3221 | Q16787 | |
| GAPGQSVTISCTGTS | 31 | A0A075B6J2 | |
| GTGTNSTNSTTAVPS | 111 | Q09328 | |
| PVCTTGQGSGSTATV | 896 | Q9H8L6 | |
| ESVPSVGNATSSSAG | 206 | Q9NPF0 | |
| LSPGGNATQSGTKTS | 4096 | Q2LD37 | |
| TTVSSQASPSGGAAL | 46 | Q86X51 | |
| PGSGSSTTQGQDVTL | 66 | P15941 | |
| PASGAAANVSTSGIT | 216 | Q96D31 | |
| NENTGSLSPSSGVGS | 121 | Q9Y6W6 | |
| GSPGQSITISCTGTS | 31 | P01705 | |
| VTGNNGSESSPATTG | 956 | P56645 | |
| TSGTGDTGPGNTAVS | 1921 | Q7Z5P9 | |
| NTPGATGSSTGQTDT | 2031 | Q7Z5P9 | |
| GQTDTSGPSAKVTGN | 2041 | Q7Z5P9 | |
| PSAGVTGTTGQSAEV | 4326 | Q7Z5P9 | |
| GTTGQSAEVTGATGQ | 5831 | Q7Z5P9 | |
| GISNTATTGVAPGTT | 6241 | Q7Z5P9 | |
| TTLVPGSSNTGATAS | 6596 | Q7Z5P9 | |
| GGTTVVSPGASSTSQ | 6821 | Q7Z5P9 | |
| QATGSLTATTGVAPG | 6881 | Q7Z5P9 | |
| NTGTTGVVSGNTISP | 7906 | Q7Z5P9 | |
| SPSSQTGDSGSQEGS | 1441 | O15018 | |
| VSSQGSVASSTGSPA | 481 | Q9H4H8 | |
| PSSSSGSQVATSGQL | 316 | O95948 | |
| PAGTHSTLQGSGTTT | 1446 | Q8TDM6 | |
| PGSVLTSSQSTGSQQ | 141 | O95600 | |
| NQSPQSVGSSGVDSG | 436 | Q14693 | |
| GSPGQSVTISCTGTS | 31 | A0A075B6J9 | |
| LSSGSLSEQGTGQTP | 146 | Q8N3F8 | |
| INNGTSPETTTSGGC | 41 | H0YM25 | |
| TVTGSGTQTQAGATQ | 226 | Q9UBG3 | |
| FGINVATPGSSATTG | 1091 | A8CG34 | |
| STATSTPFTGGLGQN | 1116 | A8CG34 | |
| FGINVATPGSSATTG | 696 | A6NF01 | |
| GQVPSTTATTPGNSG | 531 | Q14686 | |
| FGINVATPGSSTTTG | 1111 | Q96HA1 | |
| GGNLTTSSGTFISPN | 1166 | O60494 | |
| ISGSQTGSSGVISPQ | 436 | Q8IZD4 | |
| PSLGSAVQSGSSGSN | 551 | Q6AI39 | |
| GSVQGDSQGTPTSSQ | 141 | Q9Y2E4 | |
| TTTNQGASAAGPGFS | 766 | Q9UQ88 | |
| QTSSPSASSNISGGI | 31 | P31358 | |
| GEQGSTGGTNISSTS | 521 | Q16610 | |
| SQGGNDTSPTGNSTP | 261 | Q9NRM1 | |
| SITQGNTEDQGSGPS | 486 | Q14746 | |
| GSEQSTVSGAGSFPQ | 736 | Q9Y467 | |
| STPTQGSVLFGTVNG | 1021 | Q16531 | |
| NQVSPSSPSSGAGGS | 701 | Q96JN8 | |
| IATDNGSPVATGTGT | 566 | P12830 | |
| GSVTGSQSNAVSPTP | 1231 | P0C0L4 | |
| NGSQASTSIGVGTEG | 461 | Q8IXS8 | |
| GSPGQSVTISCTGTS | 31 | P01706 | |
| TTGSGQEPGQSGTSL | 321 | Q53GL7 | |
| QSSDTEQQSPTSGGG | 496 | P23588 | |
| TGANTNTTSSGQGTV | 206 | P23511 | |
| GSPGQSITISCTGTS | 31 | P01704 | |
| SKASSGGQSNPGSST | 416 | Q8IVI9 | |
| EGSSSPTTAGGTSIQ | 2021 | Q685J3 | |
| QETQPAEGTSGATTG | 86 | Q12805 | |
| VASGGTSPQPTSTQN | 276 | Q8NET4 | |
| QTLSEGSPGSSQSGS | 791 | O94972 | |
| GSPGQSVTISCTGTS | 31 | P01709 | |
| VSEASPGSTASQTGV | 116 | P22670 | |
| TTAGSGLPTGSTSNI | 1811 | Q8NFP9 | |
| GVVPGTANTSVVTSG | 2291 | O75376 | |
| AGSNGNSVTTPGNSV | 411 | Q8TBZ3 | |
| GNTQPSGNTASVQGS | 731 | Q9NZP6 | |
| SGNTASVQGSTSLPA | 736 | Q9NZP6 | |
| LNIGQGQSGTPSTTS | 1036 | Q9NZP6 | |
| ADGTQCPSGSSGTTV | 431 | Q8IZF2 | |
| PSGGNATTQTTSLSA | 761 | Q01973 | |
| TSSTGAQAVAEPTGQ | 41 | O75333 | |
| QTGPTGGASNNSETS | 901 | Q15468 | |
| VIPSSGSGSGNQSID | 316 | Q9ULJ3 | |
| LSESGGENGTTTQPT | 421 | Q6ZU65 | |
| IFGTGNGSTSSSPNI | 431 | Q9UGH3 | |
| GSGSGQQSVTGVEAS | 61 | Q9HCN8 | |
| QQGSVSGIGTVNTSA | 741 | Q02447 | |
| TQAQSTGQGGLSAPS | 976 | Q12968 | |
| GPGASSNNTTTSGFG | 1276 | P49790 | |
| APTSGVTQTNGNNTG | 356 | Q8IYW5 | |
| TRTTSVGPSNSGGSL | 746 | Q8IYT8 | |
| VSIGGGNTSAVSPSS | 386 | O95789 | |
| ETTGPGTAGPQSNTT | 1706 | Q5VWN6 | |
| GTAGPQSNTTSSLKG | 1711 | Q5VWN6 | |
| GQSQGQPSSSSLTGV | 716 | Q9H4A3 | |
| APGQGTSSTNTVGAT | 2211 | Q9H4A3 | |
| SNPLCSQSGQTSVGG | 146 | Q96IQ7 | |
| NPQAASGSTEATSGT | 2306 | Q9Y4A5 | |
| GTVSSSSNGGLNPST | 346 | Q8NDV7 | |
| FSGSITQVGSPVGSA | 881 | O95405 | |
| PSGTDTVSGQSNSGN | 431 | Q9UPQ9 | |
| SPGSTTASSLGQQST | 1511 | Q9UKN1 | |
| SPGSTTASSLGQQST | 4151 | Q9UKN1 |